Entrepreneurship, Innovation
DETERA Therapeutics, a peptide to prevent crescentic glomerulonephritis (CGN)
… - Univ. Paris-Saclay/INRAE/CEA) . These are Daniel Gillet, research director at CEA and head of the Chemical Biology Laboratory, Pierre-Louis Tharaux, nephrologist and research director at Inserm, and Lyse Santoro, a graduate of … - Univ. Paris-Saclay/INRAE/CEA) . These are Daniel Gillet, research director at CEA and head of the Chemical Biology …Published on: